Content about Bristol-Myers Squibb

November 7, 2010
RA patients may benefit from weekly injection of Orencia, study finds

Patients with rheumatoid arthritis derive about as much benefit from a weekly injection of a...

October 27, 2010
FDA OKs expanded use of Sprycel

The Food and Drug Administration has approved a new usage for a blood cancer drug,...

October 4, 2010
Mylan subsidiary gets approval for HIV generic under PEPFAR

The Food and Drug Administration has approved a generic drug for HIV made by a...

September 27, 2010
Waiting period for Bristol-ZymoGenetics deal expires

The Hart-Scott-Rodino waiting period for Bristol-Myers Squibb’s acquisition of Seattle-based biotech company ZymoGenetics has expired,...

September 23, 2010
AstraZeneca-Bristol drug just as effective as generic on market, trial results show

An investigational diabetes drug works as well as a generic already on the market, according...

September 21, 2010
Abbott recalls specific Similac powder infant formulas

Abbott on Wednesday initiated a proactive, voluntary recall of certain Similac powder infant formulas in...

September 12, 2010
Gilead: 'Quad' anti-retroviral drug as effective as competitor

An investigational treatment for HIV by Gilead Sciences that combines four drugs in one tablet...

September 9, 2010
Bristol-Myers Squibb commences tender offer for ZymoGenetics

Bristol-Myers Squibb formally has begun its tender offer for biotech company ZymoGenetics, the drug maker...

September 7, 2010
Bristol-Myers Squibb to acquire ZymoGenetics

Bristol-Myers Squibb will acquire Seattle-based biotech ZymoGenetics, Bristol said Wednesday....

August 17, 2010
FDA grants priority review for Bristol-Myer Squibb's skin cancer treatment

The Food and Drug Administration has agreed to expedite review of an investigational treatment for...

August 10, 2010
Generic unipolar depression drugs may shrink market size

The drug market for unipolar depression will get smaller over the next decade due to...

July 21, 2010
Tibotec unveils efficacy results for investigational HIV drug

An investigational treatment for HIV made by Johnson & Johnson subsidiary Tibotec Pharmaceuticals works as...

June 21, 2010
Datamonitor: Melanoma cases expected to double

Cases of the potentially deadly skin cancer melanoma are expected to almost double before the...

June 6, 2010
Bristol-Myers Squibb: Skin cancer drug increased patient survival in clinical trial

An investigational drug for skin cancer that had spread to other parts of the body...

May 20, 2010
Boehringer Ingelheim's cancer drug may be 'next generation' treatment

Data from a late-stage clinical trial of an investigational drug by Boehringer Ingelheim could show...

May 20, 2010
NAD recommends more modifications for Mead Johnson's Enfamil ads

Although Mead Johnson has said it voluntarily will modify or discontinue certain advertising claims for...

May 17, 2010
Hinkaty named to Prestige Brands board

Charles Hinkaty on Monday was named to the Prestige Brands' board of directors, the company...

May 16, 2010
Lilly to present more than 50 studies at oncology conference

The cancer drug arm of Eli Lilly plans to show data from more than 50...

March 29, 2010
Plavix patent upheld by U.S. Patent and Trademark Office

The U.S. Patent and Trademark Office plans to uphold the patent protection of a blockbuster...

March 16, 2010
FDA accepts NDA for combined diabetes drug

The Food and Drug Administration has accepted an approval application for a combination pill for...

March 11, 2010
FDA adds boxed warning to Plavix

A popular drug for preventing blood clots may be less effective when taken by a...

March 8, 2010
Bristol-Myers Squibb, AstraZeneca announce postmarketing study for Onglyza

Two drug makers hope to find out how well a diabetes drug works in treating...

March 7, 2010
Bristol-Myers Squibb, Isis announce partnership for cholesterol drug

Bristol-Myers Squibb has paid Isis Pharmaceuticals a $6 million milestone payment for regulatory approval to...

March 3, 2010
Bristol-Myers Squibb discusses pipeline with investors

Aims of becoming a leader in biotechnology headlined a meeting Thursday between Bristol-Myers Squibb and...

March 2, 2010
Allergan licenses pain drug to Bristol-Myers Squibb

Bristol-Myers Squibb is buying most of the rights to an investigational pain drug for $40...

© 2013 Drug Store News. All Rights Reserved.